These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2446056

  • 1. Ketanserin versus nifedipine in the treatment of essential hypertension in patients over 50 years old: an international multicenter study.
    Hannedouche T, Fillastre JP, Mimran A, de Tréglodé D, Schardt F, Rosenthal T, Grossman E, Rocco S.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S107-12. PubMed ID: 2446056
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of a new antihypertensive agent ketanserin versus methyldopa in the treatment of essential hypertension in older patients: an international multicenter trial.
    Zin C, Copertari P, Landi E, San Martin C, Lopes M, Feruglio F, Alcocer L.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S113-8. PubMed ID: 2446057
    [Abstract] [Full Text] [Related]

  • 3. Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years: two international multicentre studies. For the International Study Group.
    Janssens M, Symoens J.
    J Hypertens Suppl; 1986 Dec; 4(6):S115-8. PubMed ID: 3302148
    [Abstract] [Full Text] [Related]

  • 4. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L, Da Col PG.
    Clin Ther; 1989 Dec; 11(3):363-72. PubMed ID: 2663164
    [Abstract] [Full Text] [Related]

  • 5. [Cardiac interactions between ketanserin and the calcium antagonist nifedipine].
    Alberio L, Beretta-Piccoli C, Tanzi F, Koch P, Zehender M.
    Schweiz Med Wochenschr; 1992 Nov 07; 122(45):1723-7. PubMed ID: 1279788
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive efficacy of ketanserin alone or in combination with a beta-blocker or a diuretic: the Swiss Ketanserin Study.
    Beretta-Piccoli C, Amstein R, Bertel O, Brunner HR, Bühler FR, Follath F, Solèr M, Vallotton M.
    J Cardiovasc Pharmacol; 1987 Nov 07; 10 Suppl 3():S119-23. PubMed ID: 2446058
    [Abstract] [Full Text] [Related]

  • 7. Multicenter study with ketanserin in essential hypertension: an Argentine experiment.
    Demartini A, Pezzano R, Bernardiner E, Torres J, Genta C, Scheijgrond H, Gypen L.
    J Cardiovasc Pharmacol; 1987 Nov 07; 10 Suppl 3():S135-7. PubMed ID: 2446062
    [Abstract] [Full Text] [Related]

  • 8. [Blood pressure lowering action and tolerance of ketanserin in mono- or combination therapy].
    Beretta-Piccoli C, Amstein R, Bühler FR, Bertel O, Brunner HR, Follath F, Reutter F, Vallotton MB.
    Schweiz Med Wochenschr; 1989 Mar 25; 119(12):399-406. PubMed ID: 2711155
    [Abstract] [Full Text] [Related]

  • 9. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.
    J Hypertens; 1998 Nov 25; 16(11):1357-69. PubMed ID: 9856375
    [Abstract] [Full Text] [Related]

  • 10. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.
    J Hypertens; 1998 Sep 25; 16(9):1357-69. PubMed ID: 9746123
    [Abstract] [Full Text] [Related]

  • 11. Sublingual and intravenous ketanserin versus sublingual nifedipine in the treatment of severe hypertension: a randomized study.
    Sechi LA, Tedde R, Cassisa L, Pala A, Orecchioni C, Uneddu F, Melis A.
    Clin Ther; 1989 Sep 25; 11(6):834-40. PubMed ID: 2692825
    [Abstract] [Full Text] [Related]

  • 12. Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Nifedipine-Atenolol Study Review Committee.
    Nifedipine-Atenolol Study Review Committee.
    Br Med J (Clin Res Ed); 1988 Feb 13; 296(6620):468-72. PubMed ID: 2894883
    [Abstract] [Full Text] [Related]

  • 13. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
    de Roa ER, Botero R, Octavio JA, Berrizbeitia ML, Mayorca E, Castro P, Miranda R, Valecillo E, Aroca G, Aza G, González M.
    Am J Ther; 2007 Feb 13; 14(2):140-6. PubMed ID: 17414581
    [Abstract] [Full Text] [Related]

  • 14. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A.
    Blood Press Suppl; 1995 Feb 13; 3():38-46. PubMed ID: 8535541
    [Abstract] [Full Text] [Related]

  • 15. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A, Ceccanti M, Assogna G, Romeo M, Cavaleri G, Attilia ML.
    Int J Clin Pharmacol Res; 1988 Feb 13; 8(5):321-5. PubMed ID: 3068159
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
    Fagan TC, Haggert BE, Liss C.
    Clin Ther; 1994 Feb 13; 16(4):634-46. PubMed ID: 7982251
    [Abstract] [Full Text] [Related]

  • 17. [Antihypertensive effect and tolerance to urapidil. Comparison with nifedipine in a multicenter double-blind study].
    Stumpe KO, Feldhaus P, Haerlin R.
    Fortschr Med; 1989 Jan 15; 107(1):54-7. PubMed ID: 2646188
    [Abstract] [Full Text] [Related]

  • 18. Clinical experience with long-term nitrendipine treatment in essential hypertension.
    Tourkantonis A, Lasaridis A, Settas L.
    J Cardiovasc Pharmacol; 1984 Jan 15; 6 Suppl 7():S1090-5. PubMed ID: 6085373
    [Abstract] [Full Text] [Related]

  • 19. [Effects of ketanserin on arterial pressure at rest and during physical exercise in essential arterial hypertension].
    Gambini G, Gradoli C, Proietti MG, Pinchi G, Fioroni E, Valori C.
    Clin Ter; 1989 Jul 31; 130(2):101-7. PubMed ID: 2529082
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 31; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.